VIAVI Solutions benefits from every fight in the interconnect layer, since copper versus optical and pluggable versus co-packaged all raise test intensity whoever wins. Its quarter beat cleanly: revenue rose 52.5% to $443.1 million, operating margin expanded 960bp to 24%, and Q1 EPS guidance of $0.40-0.42 crushed the $0.28 estimate. The test segment grew 69.2%. CEO Oleg Khaykin called CPO delay fears nonsense, saying yield issues mean more testing, with CPO revenue starting this quarter. x.com  … Show more

VIAVI is a picks-and-shovels winner as AI data-center optical testing becomes its main growth driver. Revenue rose 42.8% to $406.8M on data-center and aerospace and defense demand, non-GAAP EPS jumped 80% to $0.27 with a 21% operating margin, and its network and service enablement segment grew 54.4% as Spirent contributes. Next-quarter guidance calls for $427-437M of revenue. The photonics buildout needs high-volume test and measurement, and data-center capex is surging. x.com  x.com 

Viavi Solutions can reach $90-$100 by 2028 as earnings scale and it keeps its rerating as an AI hardware enabler. It once traded at 13-16x forward earnings as slow-growth telecom instrumentation, but now trades near 38x 2027 estimates. Consensus non-GAAP EPS rises from about $0.94 in FY2026 to $1.83 by FY2028, and a bull case with stronger Spirent synergies reaches $2.25-$2.50. As a premier testing bottleneck for 1.6T and 3.2T optical deployments, it can sustain a 38-40x multiple. x.com 

Viavi remains a bottleneck play worth holding after beating estimates and guiding above consensus. Per @MartyChargin, quarterly EPS of $0.27 beat by $0.04 and revenue rose 42.8% to $406.8M, while June-quarter guidance of $0.29-0.31 EPS and $427-437M revenue tops consensus. x.com 

Optical test makers such as FormFactor, Aehr Test Systems and Viavi should keep growing whichever optical path wins, because every interconnect, pluggable, near-packaged or co-packaged, must be tested. Optical stocks plunged after a June report of CPO shipment delays, and engineers now point to a growing role for near-packaged optics and possible delays in some scale-up CPO. That shifts the question to who benefits as both grow, and testing is the bottleneck behind every other AI bottleneck. … Show more

Viavi Solutions is one of the best ways to play co-packaged optics and photonics, and the dilution-driven dip is a good entry. Viavi is raising $500M to repay its $450M Term Loan B, about 2% dilution that cleans up the balance sheet, yet shares fell almost 6% after hours. At roughly 39x 2027 estimates it is cheap versus photonics and CPO peers, and fundamentally less risky. CPO is a 2028-and-beyond story, so this is a longer-term holding. x.com  x.com  x.com  x.com  x.com 

Viavi's earnings were incredible, with revenue up 52.5% to $443.1M and non-GAAP operating margin rising to 24.0% from 14.4%. Non-GAAP EPS jumped to $0.34 from $0.13, which should drive a huge day for the stock. x.com 

Credo's post-earnings selloff is overdone, reflecting normalizing hypergrowth and first-quarter DustPhotonics costs rather than any demand break. Q1 revenue rose 115% to $479M, its seventh straight triple-digit quarter, Q2 guidance of $525-535M beat the Street, and FY27 optical revenue is targeted at $600M+ as optics outgrows AECs. Management sees thousands of dollars of Credo content per GPU. Risks include customer concentration, Broadcom and Marvell in optical DSPs, and new AEC rivals. x.com  … Show more

AI bandwidth demand still favors Coherent and Lumentum, but tight customer financing can delay orders and lasting valuations need durable profits. A model provider losing share need not reduce total bandwidth use. Coherent could beat and raise guidance; Lumentum may only meet estimates this quarter, improving next quarter. If margins partly reflect scarce indium phosphide, added supply will test whether upgrades, volume and cost gains sustain earnings. These earnings calls remain forecasts. … Show more

Applied Optoelectronics looks set for its next leg as AI data-center transceiver demand outstrips supply. Q2 EPS was $0.06 versus $0.02 expected and revenue rose 86.3% to $191.92M, a fifth straight record. Management guides to about $1.1B of 2026 revenue as a new Texas facility ramps capacity. The stock has formed a rounding bottom since September and is curling back through its 200 EMA; the trigger is $116.90. x.com